BioSpace News Archive

Business

Aerovate Therapeutics Launches with $72 Million and Repurposed Cancer Drug for PAH

Aerovate Therapeutics secured $72.6 million in Series A funding to advance trials of AV-101, an inhaled, dry powder aerosol version of Novartis’ cancer drug Gleevec (imatinib) in a repurposed effort to treat pulmonary arterial hypertension (PAH).

August 7, 2020
·
3 min read
·
Alex Keown
Genetown

Vigeo’s Tumor Microenvironment Platform Expands Indications and Combo Therapy Possibilities

Vigeo Therapeutics is expanding indications for its tumor microenvironment (TME)-targeting oncology platform, which inhibits tumor growth by reprogramming normal cells that were recruited and coopted by a tumor.

August 7, 2020
·
5 min read
·
Gail Dutton
Business

Kite, a Gilead Company, Looks to Expand Its Cell Therapy Maryland Operations

Maryland has become a key part of the strategy for Kite, a Gilead company, and its mission to find a cure for cancer.

August 7, 2020
·
3 min read
·
Alex Keown
Drug Development

Genentech’s Tecentriq Comes Up Short in Phase III Breast Cancer Study

Genentech’s checkpoint inhibitor Tecentriq combined with chemotherapy failed to hit the mark in a Phase III metastatic triple-negative breast cancer study.

August 7, 2020
·
2 min read
·
Alex Keown
Policy

White House Executive Order Aims to Boost Domestic Production of ‘Essential Drugs’

In an aim to create a strong domestic supply chain, President Donald Trump signed an Executive Order on Thursday that calls for federal agencies to purchase “essential drugs” and medical supplies that are produced in the United States, rather than from abroad as is the current practice.

August 7, 2020
·
3 min read
·
Alex Keown
Business

Novavax and SIPL to Develop 1 Billion COVID-19 Vaccine Doses for India, Other Countries

Novavax said the agreement will allow for the development and distribution of NVX‑CoV2373, a recombinant vaccine engineered from the genetic sequence of SARS-CoV-2, in India and in low- and middle-income countries.

August 7, 2020
·
2 min read
·
Alex Keown
Policy

FDA Accepts BLA for Biogen’s Alzheimer’s Drug, Grants Priority Review

The FDA set a PDUFA target date of March 7, 2021 for aducanumab, Biogen said.

August 7, 2020
·
2 min read
·
Alex Keown
PAP and Paracetamol Market: Developing Economies to Propel the Demand for Market

Of late, the global market for para-aminophenol and paracetamol has been witnessing a substantial surge, thanks to the rising prevalence of chronic diseases and several conditions that require pain management solutions on a regular basis.

August 7, 2020
·
4 min read
Artificial Tears Market - Increasing Demand for Advanced Products for Post-Surgery Care for Dry Eyes

The rapidly growing global geriatric population is playing an instrumental role in the growth of the global artificial tears market.

August 7, 2020
·
4 min read
BioCapital

Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK), today announced a partnership for the development, manufacturing and commercialization of NVX‑CoV2373,

August 7, 2020
·
10 min read